Wnt5a is associated with the differentiation of bone marrow mesenchymal stem cells in vascular calcification by connecting with different receptors

Molecular Medicine Reports

Volumn 10, Issue 4, 2014, Pages 1985-1991

  Guan, Siming ^a   Wang, Zhimin ^b   Xin, Fang ^a   Xin, Huaping ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b The First People's Hospital of Taizhou   (China)

Author keywords

Different receptors; Direct co cultures; Mesenchymal stem cells; Vascular calcification; Wnt5a

Indexed keywords

BETA CATENIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; LRP6 PROTEIN, RAT; MESSENGER RNA; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR; ROR2 PROTEIN, RAT; STRESS ACTIVATED PROTEIN KINASE; WNT PROTEIN; WNT5A PROTEIN, RAT;

ANIMAL; BLOOD VESSEL CALCIFICATION; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; COCULTURE; CYTOLOGY; GENETICS; HUMAN; MALE; MESENCHYMAL STROMA CELL; METABOLISM; RAT; SMOOTH MUSCLE FIBER; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-6; MALE; MESENCHYMAL STROMAL CELLS; MYOCYTES, SMOOTH MUSCLE; RATS; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; RNA, MESSENGER; VASCULAR CALCIFICATION; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84924219800     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2449     Document Type: Article

References (39)

1. Boström KI, Rajamannan NM and Towler DA: The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ Res 109: 564-577, 2011.
2. Olivares-Navarrete R, Hyzy SL, Park JH, et al: Mediation of osteogenic differentiation of human mesenchymal stem cells on titanium surfaces by a Wnt-integrin feedback loop. Biomaterials 32: 6399-6411, 2011.
3. Abedin M, Tintut Y and Demer LL: Mesenchymal stem cells and the artery wall. Circ Res 95: 671-676, 2004. (Pubitemid 39331926)
4. Leroux L, Descamps B, Tojais NF, et al: Hypoxia preconditioned mesenchymal stem cells improve vascular and skeletal muscle fiber regeneration after ischemia through a Wnt4-dependent pathway. Mol Ther 18: 1545-1552, 2010.
5. Alfaro MP, Pagni M, Vincent A, et al: The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair. Proc Natl Acad Sci USA 105: 18366-18371, 2008.
6. Moioli EK, Clark PA, Chen M, et al: Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues. PLoS One 3: e3922, 2008.
7. Qian H, Yang Y, Li J, et al: The role of vascular stem cells in atherogenesis and post-angioplasty restenosis. Ageing Res Rev 6: 109-127, 2007. (Pubitemid 47023129)
8. Bell GI, Meschino MT, Hughes-Large JM, et al: Combinatorial human progenitor cell transplantation optimizes islet regeneration through secretion of paracrine factors. Stem Cells Dev 21: 1863-1876, 2012.
9. Huang Z, Ren PG, Ma T, Smith RL and Goodman SB: Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability. Cytokine 51: 305-310, 2010.
10. Pelttari K, Winter A, Steck E, et al: Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum 54: 3254-3266, 2006. (Pubitemid 44622096)
11. Kramann R, Kunter U, Brandenburg VM, et al: Osteogenesis of heterotopically transplanted mesenchymal stromal cells in rat models of chronic kidney disease. J Bone Miner Res 28: 2523-2534, 2013.
12. Shabbir A, Zisa D, Suzuki G, Lee T: Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen. Am J Physiol Heart Circ Physiol 296: H1888-H1897, 2009.
13. Tran TC, Kimura K, Nagano M, et al: Identification of human placenta-derived mesenchymal stem cells involved in re- endothelialization. J Cell Physiol 226: 224-235, 2011.
14. Chow K, Fessel JP, Kaoriihida S, et al: Dysfunctional resident lung mesenchymal stem cells contribute to pulmonary microvascular remodeling. Pulm Circ 3: 31-49, 2013.
15. Tsaousi A, Mill C and George SJ: The Wnt pathways in vascular disease: lessons from vascular development. Curr Opin Lipidol 22: 350-357, 2011.
16. Marinou K, Christodoulides C, Antoniades C and Koutsilieris M: Wnt signaling in cardiovascular physiology. Trends Endocrinol Metab 23: 628-636, 2012.
17. Cheng CW, Yeh JC, Fan TP, et al: Wnt5a-mediated non-canonical Wnt signalling regulates human endothelial cell proliferation and migration. Biochem Biophy Res Commun 365: 285-290, 2008.
18. Ling L, Nurcombe V and Cool SM: Wnt signaling controls the fate of mesenchymal stem cells. Gene 433: 1-7, 2009.
19. Stolzing A, Jones E, McGonagle D and Scutt A: Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 129: 163-173, 2008.
20. Xin H, Xin F, Zhou S and Guan S: The Wnt5a/Ror2 pathway is associated with determination of the differentiation fate of bone marrow mesenchymal stem cells in vascular calcification. Int J Mol Med 31: 583-588, 2013.
21. Laumanns IP, Fink L, Wilhelm J, et al: The noncanonical WNT pathway is operative in idiopathic pulmonary arterial hypertension. Am J Respir Cell Mol Biol 40: 683-691, 2009.
22. Pal SN, Clancy P and Golledge J: Circulating concentrations of stem-cell-mobilizing cytokines are associated with levels of osteoprogenitor cells and aortic calcification severity. Circ J 75: 1227-1234, 2011.
23. Ball SG, Shuttleworth AC and Kielty CM: Direct cell contact influences bone marrow mesenchymal stem cell fate. Int J Biochem Cell Biol 36: 714-727, 2004. (Pubitemid 38316826)
24. Yip CY and Simmons CA: The aortic valve microenvironment and its role in calcific aortic valve disease. Cardiovasc Pathol 20: 177-182, 2011.
25. Wang T, Xu Z, Jiang W and Ma A: Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int J Cardiol 109: 74-81, 2006.
26. Mangan SH, Van Campenhout A, Rush C and Golledge J: Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-alpha associated with induction of angiopoietin-2. Cardiovasc Res 76: 494-505, 2007. (Pubitemid 350007458)
27. Menge T, Gerber M, Wataha K, et al: Human mesenchymal stem cells inhibit endothelial proliferation and angiogenesis via cell-cell contact through modulation of the VE-Cadherin/β-catenin signaling pathway. Stem Cells Dev 22: 148-157, 2013.
28. Towler DA and Demer LL: Thematic series on the pathobiology of vascular calcification: an introduction. Circ Res 108: 1378-1380, 2011.
29. Johnson ML and Rajamannan N: Diseases of Wnt signaling. Rev Endocr Metab Disord 7: 41-49, 2006. (Pubitemid 46044348)
30. Ermakov S, Trofimov S, Malkin I and Livshits G: A significant association exists between receptor tyrosine kinase-like orphan receptor 2 gene variants and the OPG/RANKL ratio in human plasma. Osteoporos Int 23: 1899-1907, 2012.
31. Qiu W, Chen L and Kassem M: Activation of non-canonical Wnt/JNK pathway by Wnt3a is associated with differentiation fate determination of human bone marrow stromal (mesenchymal) stem cells. Biochem Biophys Res Commun 413: 98-104, 2011.
32. Tian Y, Cohen ED and Morrisey EE: The importance of Wnt signaling in cardiovascular development. Pediatr Cardiol 31: 342-348, 2010.
33. Takahashi N, Maeda K, Ishihara A, Uehara S and Kobayashi Y: Regulatory mechanism of osteoclastogenesis by RANKL and Wnt signaling. Front Biosci (Landmark Ed) 16: 21-30, 2011.
34. Grumolato L, Liu G, Mong P, et al: Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev 24: 2517-2530, 2010.
35. Yuan Y, Niu CC, Deng G, et al: The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells. Int J Mol Med 27: 63-69, 2011.
36. Laird DJ, Altshuler-Keylin S, Kissner MD, et al: Ror2 enhances polarity and directional migration of primordial germ cells. PLoS Genet 7: e1002428, 2011.
37. Christman MA, Goetz DJ, Dicherson E, et al: Wnt5a is expressed in murine and human atherosclerotic lesions. Am J Physiol Heart Circ Physiol 294: H2864-H2870, 2008.
38. Mikels A, Minami Y and Nusse R: Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling. J Biol Chem 284: 30167-30176, 2009.
39. Liu Y, Rubin B, Bodine PV and Billiard J: Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase. J Cell Biochem 105: 497-502, 2008.